CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Other acquisition COO & CFO acquired 1,634 shares (other)
- 4 Open-market buy Director bought 10,000 shares at $4.49 ($44,900)
- 4 Open-market buy Director bought 10,000 shares at $3.91 ($39,100)
- 4 Open-market buy Director bought 5,000 shares at $3.99 ($19,950)
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Bylaws or fiscal year change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 45,000 shares at $4.84 ($217,800)
- 4 Open-market buy Director bought 15,600 shares at $4.88 ($76,128)
- 4 Open-market buy Director bought 10,000 shares at $4.80 ($48,000)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.86 ($24,300)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Gift Director gave 200,000 shares (gift)
Page 10 of 50 · 983 filings